SUBSCRIBE
SUBSCRIBE

Phase 1

First-Ever CRISPR Trials Points To Looming Problems
Biotech Bay
First-Ever CRISPR Trial Points to Looming Problems
June 27, 2016
 · 
5 min read
Biotech Startups Flock to the Suburbs Over Rising Rent Prices
Drug Development
Kite Pharma and Juno’s R&D Strategy to Reshape Cancer Treatment
June 21, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Scancell Suspends Dosing in Melanoma Trial Due to Quality Issues
June 17, 2016
 · 
2 min read
Drug Development
Pfizer Head of R&D Talks Strategy on How Pharma Chooses Compounds to Bet A Billion Dollars On
June 16, 2016
 · 
2 min read
Drug Development
ASCO2016: What’s Next For Cancer-Killing T-Cells After Strong ASCO Showings
June 8, 2016
 · 
1 min read
Drug Development
Why Cancer Patients And Doctors Should Rethink The Value Of Phase I Trials
June 3, 2016
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Eli Lilly Projects 20 New Product Launches in 10 Years with 20 Possible Expansions
May 24, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
13 Massachusetts Cancer Biotechs Looking to Shake Things Up at ASCO in June
May 20, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
From 20 to 84 Employees in Just Four Years, Booming Blueprint Medicines Maps Out a Plan
April 25, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Juno, Five Prime are Quiet Winners at AACR
April 21, 2016
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
ImmunoBrain Announces Nature Medicine Publication and Late-Breaking AAIC 2026 Presentation for IBC-Ab002 in Early Alzheimer’s Disease
July 14, 2026
 · 
5 min read
Press Releases
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
July 14, 2026
 · 
1 min read
Press Releases
Ernexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Study in 2026
July 14, 2026
 · 
5 min read
Press Releases
Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus
July 14, 2026
 · 
7 min read
Press Releases
Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026
July 14, 2026
 · 
6 min read
Press Releases
Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury
July 14, 2026
 · 
3 min read
Press Releases
Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome
July 14, 2026
 · 
8 min read
Press Releases
Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors
July 13, 2026
 · 
9 min read
Press Releases
Zelluna doses first solid tumour patient with ZI-MA4-1 in the ZIMA-101 Phase 1 trial
July 13, 2026
 · 
4 min read
Press Releases
Ollin Biosciences Announces Upcoming Presentations of OLN324 Data in Diabetic Macular Edema and Wet Age-Related Macular Degeneration at the American Society of Retina Specialists (ASRS) 44th Annual Scientific Meeting
July 13, 2026
 · 
2 min read
Press Releases
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
July 13, 2026
 · 
5 min read
Press Releases
Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
July 13, 2026
 · 
9 min read
Press Releases
Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types
July 13, 2026
 · 
8 min read
Press Releases
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
July 13, 2026
 · 
4 min read
Press Releases
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
July 9, 2026
 · 
7 min read
Press Releases
Astellas to Spotlight New Research for Geographic Atrophy at ASRS 2026 Annual Meeting
July 9, 2026
 · 
9 min read
Press Releases
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
July 9, 2026
 · 
7 min read
Press Releases
Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results
July 9, 2026
 · 
7 min read
Press Releases
Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer
July 9, 2026
 · 
6 min read
Press Releases
Kenai Therapeutics Announces Completion of Enrollment in Phase 1b/2a REPLACE™ Trial of RNDP-001 in Idiopathic Parkinson’s Disease
July 7, 2026
 · 
4 min read
Load More